Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing-remitting multiple sclerosis.
Greco
Anita
A
Department of Cell Biology and Neuroscience, Instituto Superiore di Sanità, Viale Regina Elena, 299, 00161, Rome, Italy. agreco@iss.it
Minghetti
Luisa
L
Puopolo
Maria
M
Cannoni
Stefania
S
Romano
Silvia
S
Pozzilli
Carlo
C
Levi
Giulio
G
D000293:Adolescent; D000328:Adult; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000134:cerebrospinal fluid; D015232:Dinoprostone / Q000134:cerebrospinal fluid; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods; D007249:Inflammation / Q000134:cerebrospinal fluid / Q000209:etiology; D028421:Isoprostanes / Q000134:cerebrospinal fluid*; D008297:Male; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000134:cerebrospinal fluid* / Q000150:complications; D009569:Nitric Oxide / Q000134:cerebrospinal fluid; D013997:Time Factors
D028421:Isoprostanes; C075750:8-epi-prostaglandin F2alpha; D009569:Nitric Oxide; D015237:Dinoprost; D015232:Dinoprostone